Mochi Health Cost: What You Actually Pay in 2026

What does Mochi Health cost per month?

Mochi bills in two parts. You pay a monthly membership for your care. You pay for the medication separately, and that price depends on your dose.

• Compounded semaglutide shot: about $140–$270 a month all-in · Medication about $60–$190 by dose
• Compounded semaglutide pill: about $140–$170 a month all-in
• Compounded tirzepatide: about $170–$280 a month all-in · Medication about $90–$200 by dose
• First month: membership free for new members · $60 all-in for semaglutide · $90 for tirzepatide
• Branded GLP-1s like Wegovy, Ozempic, Zepbound or Mounjaro: the drug price varies, and the membership still applies. See how Mochi handles insurance
• Shipping: included in the medication price

On its own, the membership is $79 a month. Prepaying brings it down:

• 3 months: about $70 a month · About $205 upfront
• 6 months: about $60 a month · About $355 upfront
• 12 months: about $50 a month · About $590 upfront

The medication keeps billing monthly on its own cycle, however you pay for the membership. Prices were checked on joinmochi.com on September 26, 2026.

Does the price go up as my dose increases?

Yes. Since August 2026, Mochi prices the medication by dose. It used to charge one flat fee. If an older review quotes a single price for every dose, that is why it no longer matches.

• Semaglutide: about $60 a month at the lowest dose, up to about $190 at the highest doses
• Tirzepatide: about $90 a month at the lowest dose, up to about $200 at the top
• Membership: the same at every dose

Even at the top, the medication usually costs less than branded cash prices. Over a year, budget near the top of each range once you reach your maintenance dose. That is the dose you stay on long term, so your starting price won't hold all year.

What does the $79 membership actually cover?

The membership pays for your care team. Mochi says it has more than 400 board-certified providers. Several of its doctors are also board-certified in obesity medicine, which means dedicated training in how weight and metabolism work. It matters in perimenopause, when hormones and metabolism shift together.

The standard plan includes regular video visits with a physician and a health coach. You also get 24/7 patient support, direct messaging with your provider and an online portal. Labs, genetic testing and sleep apnea checks are options, not automatic. A registered dietitian comes only with Mochi's insurance-based Wellness Plus plan.

• Included: video visits with a board-certified physician and a health coach
• Included: 24/7 support, provider messaging and an online portal
• Included: prescriptions at any dose level
• Not included: the medication itself, billed by dose
• Not included: lab work, which is an optional add-on
• Not included: a registered dietitian, unless you qualify for the insurance-based Wellness Plus plan
• Not included: insurance billing for the membership or compounded medication. See Mochi's insurance and FSA/HSA breakdown for branded-drug approvals and HSA details.

You can pay the membership with an HSA or FSA card. Those are pre-tax health savings accounts. Mochi can also prepare a superbill on request. That is an itemized receipt you can send to your insurer for possible partial repayment. Whether the medication qualifies for HSA or FSA depends on your plan, so check first.

How much is Mochi Health per year? The full annual math

Here is what a full year costs all-in, by dose. The first figure uses the monthly membership. The second uses the 12-month prepay.

• Semaglutide: about $1,670–$3,215 a year · About $1,310–$2,855 with the 12-month prepay
• Tirzepatide: about $2,030–$3,335 a year · About $1,670–$2,975 with the 12-month prepay
• Prepay savings: about $360 a year on the membership alone

Labs are the most likely extra cost. Most GLP-1 providers suggest checking metabolic markers before you start and again in the first year. Direct-pay lab prices vary a lot by lab and panel, so ask for a quote. If your primary care doctor orders them, your insurance may cover them.

In perimenopause or menopause, a broader first-year baseline can make sense. It might include estrogen, thyroid, cholesterol and FSH, a hormone that rises around menopause. It could also include HbA1c, a measure of average blood sugar. That baseline is useful whoever prescribes, especially if hormone therapy is on your mind. Our perimenopause labs guide covers which tests to ask for.

How does Mochi Health's price compare to competitors?

Even with per-dose pricing, Mochi stays competitive. Here is how the main compounded GLP-1 programs compare, paying month to month in cash.

Henry Meds: about $250–$350/mo, no separate membership

Henry Meds puts visits, supplies and shipping into one subscription. There is no separate membership fee, which keeps the bill simple.

• Oral semaglutide: about $250 a month
• Injectable semaglutide: about $300 a month
• Injectable tirzepatide: about $450 a month

Henry's prices drop if you prepay for longer. Mochi's per-dose pricing still comes in lower at most doses. The gap narrows at the top of Mochi's range. Full details are in the Henry Meds review and the Henry Meds cost breakdown.

Fridays: about $150–$390/mo, depending on commitment

Fridays bundles medication, doctor visits, coaching, a fitness app and messaging into one subscription. There is no separate membership fee.

• Semaglutide: about $280 a month, month to month · About $150 a month on the annual plan
• Tirzepatide: about $390 a month, month to month · About $240 a month on the annual plan
• Fall promo: codes on joinfridays.com currently lower the annual plans to about $115 (semaglutide) and $200 (tirzepatide), with no end date shown

The annual semaglutide plan is the lowest all-in price here. But it means paying for the year upfront, with limited refunds if you stop. Month to month, Mochi is competitive on both drugs. The Fridays review covers the program in depth.

Hers: about $300–$450/mo all-in, women-focused

Hers is built for women, which suits many women in perimenopause. It now centers on brand-name GLP-1s: the Wegovy pill and pen, and the Zepbound vial. It no longer leads with compounded semaglutide.

• Membership: about $150 a month · First month $39
• All-in with the Wegovy pill: about $300–$450 a month, by dose
• With the Wegovy pen or Zepbound: higher

That sits above Mochi's comparable tiers. Whether the women-first approach is worth the premium depends on what you want beyond the medication. See the Hers review and the Hers cost breakdown for every plan.

The short version: Mochi is one of the better month-to-month prices for tirzepatide. It holds its own on semaglutide, especially at lower doses. If you can prepay a year and want everything bundled, Fridays' annual semaglutide plan can undercut it. If you want one price with no separate membership, compare Henry Meds at your expected dose. Either way, compare at your maintenance dose, not your starting price.

Any hidden fees or billing surprises to know about?

Mochi's prices are clearly listed. The billing structure is the main source of frustration. The membership and the medication are two separate recurring charges. Canceling one does not cancel the other.

Many complaints come from exactly this. People thought they had canceled everything, then got billed again because only one subscription had stopped.

Refunds are limited too. Mochi treats all prescription medication sales as final, since medicine can't be returned or resold. If your situation changes mid-month, expect to pay for that cycle.

• Two subscriptions: cancel the membership and the medication separately to stop all billing
• Refunds: all prescription medication sales are final
• Labs: not included; billed as an add-on if ordered through Mochi
• Insurance: not accepted for the membership or compounded medication. Branded GLP-1s can go through insurance if a prior authorization Mochi submits is approved. That is the insurer's approval before it pays for a drug.
• Shipping: included in medication prices

The Aequita pharmacy closure: what happened and where Mochi stands now

In March 2025, Washington State regulators shut down Aequita Pharmacy. It was one of Mochi's main compounding partners at the time. The state cited sterile compounding violations, including unlicensed workers handling medicine. Mochi patients who relied on Aequita faced delays.

Mochi has since grown its network to more than 33 pharmacy partners. A new patient today will not get medicine from Aequita, which has closed. Still, the closure was serious, and it raised fair questions about oversight. Ask which pharmacy will fill your prescription, and check that it holds a current state license.

There is also a lawsuit. Eli Lilly sued Mochi Health over how it marketed compounded tirzepatide. An earlier version of the complaint was dismissed. In April 2026, a federal judge let Lilly's revised claims go forward. They fall under California's unfair competition law and the Lanham Act, a federal trademark law. The case is ongoing, with no final ruling. For the full story, see is Mochi Health legit?

The FDA 503B proposal: real risk or distant threat?

On April 30, 2026, the FDA proposed keeping semaglutide, tirzepatide and liraglutide off the 503B bulks list. That list names the bulk ingredients large outsourcing pharmacies may compound with. The FDA found no clinical need for them to use these three. The comment period was extended and closed July 30, 2026. As of this update, no final decision has been announced.

If it is finalized, 503B outsourcing facilities could no longer compound these drugs from bulk ingredients. The effect on Mochi depends on which kind of pharmacy fills your order. 503A pharmacies make medicine for one named patient at a time. They follow a different legal path and are not directly covered by this proposal. Ask your Mochi provider which type fills your prescription.

For now, Mochi keeps dispensing compounded GLP-1s. Treat this as a medium-term supply risk to watch, not an immediate disruption.

Is Mochi Health worth the cost for perimenopausal women?

Most people's dose climbs to a maintenance level, and Mochi's pricing still holds up there. Tirzepatide at its top dose runs about $280 a month all-in. That buys board-certified obesity doctors, a health coach and 24/7 support. Starting doses cost noticeably less.

Mochi also offers more choice than most. You can take semaglutide as a weekly shot or a weekly pill, or ask about its microdosing plan.

For women in perimenopause or menopause, Mochi's metabolism-focused doctors know this stage. That includes changes in insulin sensitivity, and how falling estrogen shifts where fat is stored. Mochi now also offers menopause hormone therapy, such as estradiol pills and patches and progesterone. So you may be able to handle weight and hormones in one place. It is a separate service, so ask how it is billed.

The honest caveats:

• two subscriptions to manage when you cancel
• labs not included
• a medication price that now rises with dose
• a documented pharmacy problem in its past
• a legal picture for compounded GLP-1s that is still changing

None of these are reasons to avoid Mochi outright. Each is worth knowing before you start.